0001179110-20-000703.txt : 20200122
0001179110-20-000703.hdr.sgml : 20200122
20200122171714
ACCESSION NUMBER: 0001179110-20-000703
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200117
FILED AS OF DATE: 20200122
DATE AS OF CHANGE: 20200122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manning Anthony M.
CENTRAL INDEX KEY: 0001716468
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 20539614
MAIL ADDRESS:
STREET 1: C/O PALATIN TECHNOLOGIES, INC.
STREET 2: 4B CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2020-01-17
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001716468
Manning Anthony M.
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Common Stock
2020-01-17
4
M
0
3500
A
8943
D
Common Stock
2020-01-21
4
S
0
1235
30.08
D
7708
D
Restricted Stock Units
2020-01-17
4
M
0
3500
0
D
Common Stock
3500
38500
D
Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17, 2018.
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Restricted Stock Units convert into common stock on a one-for-one basis.
Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
/s/ R. Mark Chamberlin as attorney in fact
2020-01-22